Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California 90095-1690, USA.
J Heart Lung Transplant. 2011 Jul;30(7):790-8. doi: 10.1016/j.healun.2011.02.007. Epub 2011 Apr 8.
Pulmonary non-tuberculous mycobacterial (NTM) infection is relatively common after lung transplantation, but the effect on mortality remains undetermined. Herein we describe our experience with pulmonary NTM infection after lung transplantation and hypothesized that non-tuberculous mycobacterial infection after lung transplantation would be associated with increased mortality.
We retrospectively evaluated 201 primary lung transplant recipients transplanted between January 2000 and August 2006. Serial bronchoscopies with bronchoalveolar lavage and transbronchial biopsy were performed according to a surveillance protocol and when clinically indicated. The diagnosis NTM infection was established by a positive NTM culture in a bronchoalveolar lavage sample or in at least two separate expectorated sputum samples. NTM infections were further classified as "disease" or "colonization," based on whether or not NTM infection patients developed symptoms and characteristic radiographic findings.
Thirty-six (18%) recipients were diagnosed with pulmonary NTM infection at a median of 97 days post-transplantation: 9 were classified as NTM disease and the remaining 27 as NTM colonization cases. Single lung transplant was a significant risk factor for NTM infection (HR 2.25, p = 0.02). NTM colonization was a risk factor for NTM disease (HR 8.39, p = 0.003). NTM infection significantly increased the risk of death after lung transplantation (HR 2.61, p = 0.001) and persisted in multivariate models controlling for single lung transplant and bronchiolitis obliterans syndrome. The increased risk was seen for both NTM colonization and NTM disease. Among the patients who died, non-NTM infection was a more common contributing factor in the cause of death for the NTM infection group (44% vs 12%, p = 0.04).
Non-tuberculous mycobacterial infection is common after lung transplantation. NTM colonization and treated acute rejection are risk factors for NTM disease. NTM infection is associated with increased risk of mortality independent of bronchiolitis obliterans syndrome.
肺非结核分枝杆菌(NTM)感染在肺移植后较为常见,但对死亡率的影响仍不确定。本文描述了我们在肺移植后发生肺 NTM 感染的经验,并假设肺移植后非结核分枝杆菌感染会增加死亡率。
我们回顾性评估了 201 例 2000 年 1 月至 2006 年 8 月期间进行的原发性肺移植受者。根据监测方案和临床指征,定期进行支气管镜检查,包括支气管肺泡灌洗和经支气管活检。通过支气管肺泡灌洗液或至少两份独立的咳痰样本中 NTM 培养阳性来诊断 NTM 感染。根据 NTM 感染患者是否出现症状和特征性影像学表现,将 NTM 感染进一步分为“疾病”或“定植”。
36 例(18%)受者在移植后中位时间 97 天被诊断为肺 NTM 感染:9 例为 NTM 疾病,其余 27 例为 NTM 定植病例。单肺移植是 NTM 感染的显著危险因素(HR 2.25,p=0.02)。NTM 定植是 NTM 疾病的危险因素(HR 8.39,p=0.003)。肺移植后 NTM 感染显著增加死亡风险(HR 2.61,p=0.001),并在控制单肺移植和闭塞性细支气管炎综合征的多变量模型中持续存在。NTM 定植和 NTM 疾病均增加死亡风险。在死亡患者中,非 NTM 感染是 NTM 感染组死亡原因的更常见因素(44%比 12%,p=0.04)。
肺移植后 NTM 感染较为常见。NTM 定植和治疗性急性排斥反应是 NTM 疾病的危险因素。NTM 感染与死亡率增加相关,独立于闭塞性细支气管炎综合征。